R E Scharf Selected Research

Pre-Eclampsia (Preeclampsia)

4/2005

The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R E Scharf Research Topics

Disease

5	Hemorrhage 01/2015 - 09/2007
3	Thrombocytopenia (Thrombopenia) 01/2014 - 11/2003
3	Thrombosis (Thrombus) 02/2011 - 02/2000
2	Hemophilia A (Haemophilia) 01/2015 - 01/2009
2	Neoplasms (Cancer) 11/2011 - 02/2005
2	Myocardial Infarction 07/2005 - 03/2000
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2005 - 03/2000
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2016
1	Inflammation (Inflammations) 01/2015
1	Sepsis (Septicemia) 03/2013
1	Disseminated Intravascular Coagulation 03/2013
1	Bone Cysts (Bone Cyst) 01/2009
1	Stroke (Strokes) 01/2009
1	Thrombophilia 01/2009
1	Joint Diseases (Joint Disease) 01/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2009
1	Thrombasthenia (Glanzmann Thrombasthenia) 09/2007
1	Body Weight (Weight, Body) 09/2007
1	Bernard-Soulier Syndrome (Giant Platelet Syndrome) 09/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2006
1	Pre-Eclampsia (Preeclampsia) 04/2005
1	Thrombotic Thrombocytopenic Purpura 11/2003
1	Hepatitis 05/2000
1	Hemostatic Disorders 05/2000
1	Hypertension (High Blood Pressure) 03/2000
1	Venous Thromboembolism 02/2000
1	Thromboembolism 02/2000

Drug/Important Bio-Agent (IBA)

4	factor V LeidenIBA 01/2009 - 02/2000
4	Prothrombin (Factor II)IBA 01/2009 - 02/2000
3	Heparin (Liquaemin)FDA LinkGeneric 01/2014 - 11/2003
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 03/2000
2	von Willebrand FactorIBA 01/2016 - 01/2015
2	human platelet antigen 1bIBA 07/2005 - 03/2000
1	HDL CholesterolIBA 01/2016
1	AntigensIBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	Factor VIII (Coagulation Factor VIII)IBA 01/2015
1	AutoantibodiesIBA 01/2015
1	lipoteichoic acidIBA 03/2013
1	AcidsIBA 03/2013
1	AnticoagulantsIBA 11/2011
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2011
1	Hemostatics (Antihemorrhagics)IBA 02/2011
1	Pharmaceutical PreparationsIBA 02/2011
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2009
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2009
1	recombinant FVIIa (rFVIIa)FDA Link 09/2007
1	Integrin alpha2beta1IBA 07/2005
1	IntegrinsIBA 07/2005
1	Platelet Membrane Glycoprotein IIbIBA 07/2005
1	Integrin alpha ChainsIBA 07/2005
1	Oxidoreductases (Dehydrogenase)IBA 04/2005
1	Plasminogen Activator Inhibitor 1IBA 04/2005
1	Plasminogen InactivatorsIBA 04/2005
1	Antineoplastic Agents (Antineoplastics)IBA 02/2005
1	thiamine triphosphorate (TTP)IBA 11/2003
1	Phenprocoumon (Liquamar)FDA Link 05/2000
1	CholesterolIBA 03/2000
1	Protein SIBA 02/2000
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2000
1	Protein CIBA 02/2000
1	Factor V (Coagulation Factor V)IBA 02/2000
1	AntithrombinsIBA 02/2000

Therapy/Procedure

8	Therapeutics 01/2015 - 11/2003
1	Platelet Transfusion (Blood Platelet Transfusions) 02/2011
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2009
1	Injections 09/2007
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2000